Literature DB >> 27840903

Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.

Ling Liu1, Yang Li2, Xilin Xiong2, Kai Qi2, Chi Zhang2, Jianpei Fang2, Haixia Guo2.   

Abstract

This study investigated arsenic trioxide (As2O3), cisplatin (DDP) and etoposide (Vp16) on the anticancer effects and P-glycoprotein (P-gp) expression in neuroblastoma (NB) SK-N-SH cells. The potential influence of As2O3, DDP and Vp16 currently included in NB routine treatment protocols on cytotoxicity in SK-N-SH cells was measured by flow cytometry and drug half-maximal inhibitory concentration (IC50) was established. Moreover, chemotherapeutic agent-mediated changes of cellular expression levels of resistant-related P-gp, was monitored using western blotting. The data showed that As2O3, DDP and Vp16 significantly inhibited the growth and survival of the SK-N-SH cells at different concentration. Notably, the levels of apoptosis were upregulated in SK-N-SH cells with an acceleration of the exposure time and the concentration of As2O3, DDP and Vp16. As2O3, DDP and Vp16 were observed with their IC50 values on SK-N-SH cells being 3 µM, 8 and 100 µg/ml, respectively. Flow cytometry analysis showed that As2O3 at low concentrations in SK-N-SH cells led to enhanced accumulation of cell populations in G2/M phase with increasing the exposure time, and increased levels of apoptosis. In contrast, we observed that SK-N-SH cell populations arrested in S phase by DDP and Vp16. In vitro examination revealed that following pretreatment of SK-N-SH cells with As2O3, the expression of P-gp was not increased. The expression of P-gp downregulation were noted following the group treated by As2O3 at 2 and 3 µM. Exposed to As2O3 at 3 µM for 72 h, SK-N-SH cells exhibited lower expression of P-gp than 2 µM As2O3 for 72 h. In contrast, the expression of P-gp was upregulated by DDP and VP16. In summary, SK-N-SH cells were responsive to chemotherapeutic agent-induced apoptosis in a dose-dependent and time-dependent manner. In particular, ours findings showed that low dose of As2O3 markedly reduced the P-gp expression and increased apoptotic cell death in human NB cell line.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27840903     DOI: 10.3892/ijo.2016.3756

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Arsenic trioxide increases apoptosis of SK-N-BE (2) cells partially by inducing GPX4-mediated ferroptosis.

Authors:  Chuchu Feng; Yu Wu; Yantao Chen; Xilin Xiong; Peng Li; Xiaomin Peng; Chunmou Li; Wenjun Weng; Yafeng Zhu; Dunhua Zhou; Yang Li
Journal:  Mol Biol Rep       Date:  2022-05-22       Impact factor: 2.742

2.  Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.

Authors:  Jun You; Yuwen Han; Haifeng Qiao; Yun Han; Xiaoyan Lu; Yiling Lu; Xiaoyu Wang; Haili Kai; Yanli Zheng
Journal:  Aging (Albany NY)       Date:  2022-06-10       Impact factor: 5.955

3.  Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.

Authors:  Bing-Bing Zhang; Xiao-Jie Chen; Xu-Dong Fan; Jing-Jing Zhu; Ying-Hui Wei; Hang-Sheng Zheng; Hong-Yue Zheng; Bin-Hui Wang; Ji-Gang Piao; Fan-Zhu Li
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

4.  Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells.

Authors:  Xilin Xiong; Yang Li; Ling Liu; Kai Qi; Chi Zhang; Yueqin Chen; Jianpei Fang
Journal:  Biol Res       Date:  2018-06-13       Impact factor: 5.612

5.  Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial.

Authors:  Chunmou Li; Xiaomin Peng; Chuchu Feng; Xilin Xiong; Jianxin Li; Ning Liao; Zhen Yang; Aiguo Liu; Pingping Wu; Xuehong Liang; Yunyan He; Xin Tian; Yunbi Lin; Songmi Wang; Yang Li
Journal:  Oncol Res       Date:  2021-04-15       Impact factor: 5.574

6.  Improved Outcomes with Induction Chemotherapy Combined with Arsenic Trioxide in Stage 4 Neuroblastoma: A Case Series.

Authors:  Yang Li; Chuchu Feng; Yantao Chen; Ke Huang; Chunmou Li; Xilin Xiong; Peng Li; Dunhua Zhou; Xiaomin Peng; Wenjun Weng; Xiaogeng Deng; Yaohao Wu; Jianpei Fang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.